| Also known as |
Allopurinol |
| Blood pressure |
No significant effect |
| Chemical name |
1H-pyrazolo[3,4-d]pyrimidin-4-ol |
| Dosage (medical) |
Typically 100-300 mg daily, may be increased to 600 mg daily in severe cases |
| Dosage (sports) |
Not applicable |
| Effects |
Lowers serum and urinary uric acid levels |
| Formula |
C5H4N4O |
| Half-life |
1 to 2 hours |
| Hepatotoxicity |
Rare but possible liver enzyme abnormalities |
| Lab Test |
Uric acid levels |
| Main action |
Reduces uric acid production |
| Side effects |
Rash, Stevens-Johnson syndrome, gastrointestinal disturbance, liver enzyme abnormalities |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Strength |
300 mg |
| Substance class |
Xanthine oxidase inhibitor |
| Trade name |
Zyloprim, Aloprim |
| Use in sports |
Not typically used in sports |
| Water Retention |
No significant effect |
| Manufacturer |
Cipla |
